Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125023312 | 12502331 | 2 | F | 20160527 | 20160713 | 20160627 | 20160728 | PER | US-009507513-1606USA009215 | MERCK | 77.19 | YR | F | Y | 0.00000 | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125023312 | 12502331 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | M012052 | 21995 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 125023312 | 12502331 | 2 | C | COMBIGAN | BRIMONIDINE TARTRATETIMOLOL MALEATE | 1 | UNK | U | 0 | ||||||||||
| 125023312 | 12502331 | 3 | C | ADEMETIONINE | ADEMETIONINE | 1 | UNK | U | 0 | ||||||||||
| 125023312 | 12502331 | 4 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125023312 | 12502331 | 1 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125023312 | 12502331 | Blood glucose abnormal | |
| 125023312 | 12502331 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |